New active ingredients for drugs to treat infections, cancer or other serious diseases are often based on substances originally discovered in microorganisms, plants or other living organisms.
Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- "Artificial Intelligence in Drug Discovery Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The ...
By Sriparna Roy Oct 21 (Reuters) - Life sciences firm Danaher is well positioned to benefit as drugmakers increasingly adopt artificial intelligence to develop new medicines, its chief executive said ...
A new review argues that AI-driven antiviral discovery must be benchmarked against respiratory RNA virus polymerases under ...
Avner Schlessinger, PhD, right, working with his lab researchers at Mount Sinai AI Small Molecule Drug Discovery Center in New York City. [Mount Sinai] Most breakthrough discoveries are made based on ...
Are Ian’s AI biotech stories isolated breakthroughs or the start of something bigger? This week’s chart offers a compelling ...
In drug discovery, scientists identify promising compounds and work to develop them into effective therapeutics. However, they often struggle to navigate expansive compound libraries and prioritize ...
In recent years, the artificial intelligence (AI) conversation has been dominated by increasingly capable large language models. Every few months, models improve on mathematical reasoning and coding ...
How is artificial intelligence transforming the way consumers discover brands and products online? In this conversation with Beet.TV's David Kaplan, Ben Hovaness, EVP of Specialized Capabilities at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results